Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.

Identifieur interne : 000785 ( PubMed/Checkpoint ); précédent : 000784; suivant : 000786

Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.

Auteurs : Tamir Dingjan [Australie] ; Anne Imberty [France] ; Serge Pérez [France] ; Elizabeth Yuriev [Australie] ; Paul A. Ramsland [Australie]

Source :

RBID : pubmed:28680402

Abstract

Burkholderia ambifaria is an opportunistic respiratory pathogen belonging to the Burkholderia cepacia complex, a collection of species responsible for the rapidly fatal cepacia syndrome in cystic fibrosis patients. A fucose-binding lectin identified in the B. ambifaria genome, BambL, is able to adhere to lung tissue, and may play a role in respiratory infection. X-ray crystallography has revealed the bound complex structures for four fucosylated human blood group epitopes (blood group B, H type 1, H type 2, and Le(x) determinants). The present study employed computational approaches, including docking and molecular dynamics (MD), to extend the structural analysis of BambL-oligosaccharide complexes to include four additional blood group saccharides (A, Le(a), Le(b), and Le(y)) and a library of blood-group-related carbohydrates. Carbohydrate recognition is dominated by interactions with fucose via a hydrogen-bonding network involving Arg15, Glu26, Ala38, and Trp79 and a stacking interaction with Trp74. Additional hydrogen bonds to non-fucose residues are formed with Asp30, Tyr35, Thr36, and Trp74. BambL recognition is dominated by interactions with fucose, but also features interactions with other parts of the ligands that may modulate specificity or affinity. The detailed computational characterization of the BambL carbohydrate-binding site provides guidelines for the future design of lectin inhibitors.

DOI: 10.3389/fphar.2017.00393
PubMed: 28680402


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28680402

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.</title>
<author>
<name sortKey="Dingjan, Tamir" sort="Dingjan, Tamir" uniqKey="Dingjan T" first="Tamir" last="Dingjan">Tamir Dingjan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Imberty, Anne" sort="Imberty, Anne" uniqKey="Imberty A" first="Anne" last="Imberty">Anne Imberty</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre de Recherches sur les Macromolécules Végétales, Centre National de la Recherche Scientifique UPR5301, Université Grenoble AlpesGrenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre de Recherches sur les Macromolécules Végétales, Centre National de la Recherche Scientifique UPR5301, Université Grenoble AlpesGrenoble</wicri:regionArea>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Perez, Serge" sort="Perez, Serge" uniqKey="Perez S" first="Serge" last="Pérez">Serge Pérez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de Pharmacochimie Moléculaire, Centre National de la Recherche Scientifique, UMR5063, Université Grenoble AlpesGrenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de Pharmacochimie Moléculaire, Centre National de la Recherche Scientifique, UMR5063, Université Grenoble AlpesGrenoble</wicri:regionArea>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yuriev, Elizabeth" sort="Yuriev, Elizabeth" uniqKey="Yuriev E" first="Elizabeth" last="Yuriev">Elizabeth Yuriev</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ramsland, Paul A" sort="Ramsland, Paul A" uniqKey="Ramsland P" first="Paul A" last="Ramsland">Paul A. Ramsland</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Science, RMIT UniversityMelbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Science, RMIT UniversityMelbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28680402</idno>
<idno type="pmid">28680402</idno>
<idno type="doi">10.3389/fphar.2017.00393</idno>
<idno type="wicri:Area/PubMed/Corpus">000A91</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A91</idno>
<idno type="wicri:Area/PubMed/Curation">000A88</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A88</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A88</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A88</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.</title>
<author>
<name sortKey="Dingjan, Tamir" sort="Dingjan, Tamir" uniqKey="Dingjan T" first="Tamir" last="Dingjan">Tamir Dingjan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Imberty, Anne" sort="Imberty, Anne" uniqKey="Imberty A" first="Anne" last="Imberty">Anne Imberty</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre de Recherches sur les Macromolécules Végétales, Centre National de la Recherche Scientifique UPR5301, Université Grenoble AlpesGrenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre de Recherches sur les Macromolécules Végétales, Centre National de la Recherche Scientifique UPR5301, Université Grenoble AlpesGrenoble</wicri:regionArea>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Perez, Serge" sort="Perez, Serge" uniqKey="Perez S" first="Serge" last="Pérez">Serge Pérez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Département de Pharmacochimie Moléculaire, Centre National de la Recherche Scientifique, UMR5063, Université Grenoble AlpesGrenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de Pharmacochimie Moléculaire, Centre National de la Recherche Scientifique, UMR5063, Université Grenoble AlpesGrenoble</wicri:regionArea>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
<wicri:noRegion>Université Grenoble AlpesGrenoble</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yuriev, Elizabeth" sort="Yuriev, Elizabeth" uniqKey="Yuriev E" first="Elizabeth" last="Yuriev">Elizabeth Yuriev</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ramsland, Paul A" sort="Ramsland, Paul A" uniqKey="Ramsland P" first="Paul A" last="Ramsland">Paul A. Ramsland</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Science, RMIT UniversityMelbourne, VIC, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Science, RMIT UniversityMelbourne, VIC</wicri:regionArea>
<wicri:noRegion>VIC</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Frontiers in pharmacology</title>
<idno type="ISSN">1663-9812</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Burkholderia ambifaria is an opportunistic respiratory pathogen belonging to the Burkholderia cepacia complex, a collection of species responsible for the rapidly fatal cepacia syndrome in cystic fibrosis patients. A fucose-binding lectin identified in the B. ambifaria genome, BambL, is able to adhere to lung tissue, and may play a role in respiratory infection. X-ray crystallography has revealed the bound complex structures for four fucosylated human blood group epitopes (blood group B, H type 1, H type 2, and Le(x) determinants). The present study employed computational approaches, including docking and molecular dynamics (MD), to extend the structural analysis of BambL-oligosaccharide complexes to include four additional blood group saccharides (A, Le(a), Le(b), and Le(y)) and a library of blood-group-related carbohydrates. Carbohydrate recognition is dominated by interactions with fucose via a hydrogen-bonding network involving Arg15, Glu26, Ala38, and Trp79 and a stacking interaction with Trp74. Additional hydrogen bonds to non-fucose residues are formed with Asp30, Tyr35, Thr36, and Trp74. BambL recognition is dominated by interactions with fucose, but also features interactions with other parts of the ligands that may modulate specificity or affinity. The detailed computational characterization of the BambL carbohydrate-binding site provides guidelines for the future design of lectin inhibitors.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">28680402</PMID>
<DateCreated>
<Year>2017</Year>
<Month>07</Month>
<Day>06</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>08</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1663-9812</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<PubDate>
<Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in pharmacology</Title>
<ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.</ArticleTitle>
<Pagination>
<MedlinePgn>393</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2017.00393</ELocationID>
<Abstract>
<AbstractText>Burkholderia ambifaria is an opportunistic respiratory pathogen belonging to the Burkholderia cepacia complex, a collection of species responsible for the rapidly fatal cepacia syndrome in cystic fibrosis patients. A fucose-binding lectin identified in the B. ambifaria genome, BambL, is able to adhere to lung tissue, and may play a role in respiratory infection. X-ray crystallography has revealed the bound complex structures for four fucosylated human blood group epitopes (blood group B, H type 1, H type 2, and Le(x) determinants). The present study employed computational approaches, including docking and molecular dynamics (MD), to extend the structural analysis of BambL-oligosaccharide complexes to include four additional blood group saccharides (A, Le(a), Le(b), and Le(y)) and a library of blood-group-related carbohydrates. Carbohydrate recognition is dominated by interactions with fucose via a hydrogen-bonding network involving Arg15, Glu26, Ala38, and Trp79 and a stacking interaction with Trp74. Additional hydrogen bonds to non-fucose residues are formed with Asp30, Tyr35, Thr36, and Trp74. BambL recognition is dominated by interactions with fucose, but also features interactions with other parts of the ligands that may modulate specificity or affinity. The detailed computational characterization of the BambL carbohydrate-binding site provides guidelines for the future design of lectin inhibitors.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dingjan</LastName>
<ForeName>Tamir</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Imberty</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Centre de Recherches sur les Macromolécules Végétales, Centre National de la Recherche Scientifique UPR5301, Université Grenoble AlpesGrenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pérez</LastName>
<ForeName>Serge</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Département de Pharmacochimie Moléculaire, Centre National de la Recherche Scientifique, UMR5063, Université Grenoble AlpesGrenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yuriev</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityMelbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramsland</LastName>
<ForeName>Paul A</ForeName>
<Initials>PA</Initials>
<AffiliationInfo>
<Affiliation>School of Science, RMIT UniversityMelbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Surgery Austin Health, University of MelbourneMelbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Immunology, Central Clinical School, Monash UniversityMelbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Burnet InstituteMelbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>06</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Pharmacol</MedlineTA>
<NlmUniqueID>101548923</NlmUniqueID>
<ISSNLinking>1663-9812</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Inf Model. 2014 Oct 27;54(10):2744-50</RefSource>
<PMID Version="1">25289680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cyst Fibros. 2004 Jun;3(2):133-4</RefSource>
<PMID Version="1">15463897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Chem. 2006 Oct 19;49(21):6177-96</RefSource>
<PMID Version="1">17034125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proteins. 2010 Jun;78(8):1950-8</RefSource>
<PMID Version="1">20408171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2015;1331:41-55</RefSource>
<PMID Version="1">26169734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Chem. 2004 Mar 25;47(7):1739-49</RefSource>
<PMID Version="1">15027865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Cell Biol. 2005 Dec;83(6):709-17</RefSource>
<PMID Version="1">16266323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 2000 Jan 1;28(1):235-42</RefSource>
<PMID Version="1">10592235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Graph Model. 2013 Mar;40:80-90</RefSource>
<PMID Version="1">23376613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioinformatics. 2013 Apr 1;29(7):845-54</RefSource>
<PMID Version="1">23407358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Biol. 2003 Dec;10(12):980</RefSource>
<PMID Version="1">14634627</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Recognit. 2015 Oct;28(10):581-604</RefSource>
<PMID Version="1">25808539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Chem. 2004 Mar 25;47(7):1750-9</RefSource>
<PMID Version="1">15027866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2010 Jun 18;584(12):2548-55</RefSource>
<PMID Version="1">20417206</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Syst Bacteriol. 1997 Oct;47(4):1188-200</RefSource>
<PMID Version="1">9336927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2006 Apr;1760(4):527-37</RefSource>
<PMID Version="1">16564136</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2011 Jul 30;32(10):2319-27</RefSource>
<PMID Version="1">21500218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Recognit. 2001 May-Jun;14(3):172-84</RefSource>
<PMID Version="1">11391788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2016 Aug 26;477(3):477-82</RefSource>
<PMID Version="1">27318092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Biol. 2002 Dec;9(12):918-21</RefSource>
<PMID Version="1">12415289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochemistry. 2003 Sep 30;42(38):11093-9</RefSource>
<PMID Version="1">14503859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Microbiol. 2011 Jul 22;2:159</RefSource>
<PMID Version="1">21811491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Res Notes. 2012 Jul 23;5:367</RefSource>
<PMID Version="1">22824207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2008 Mar;29(4):622-55</RefSource>
<PMID Version="1">17849372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr D Biol Crystallogr. 2015 Mar;71(Pt 3):442-53</RefSource>
<PMID Version="1">25760594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 Aug 19;8(8):e71149</RefSource>
<PMID Version="1">23976992</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Respir Crit Care Med. 2009 Oct;30(5):596-610</RefSource>
<PMID Version="1">19760547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 Feb 22;277(8):6615-21</RefSource>
<PMID Version="1">11714721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(10):e46032</RefSource>
<PMID Version="1">23056230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biophys J. 2015 Oct 20;109 (8):1528-32</RefSource>
<PMID Version="1">26488642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycoconj J. 2001 Sep;18(9):649-59</RefSource>
<PMID Version="1">12386452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Inf Model. 2012 May 25;52(5):1250-61</RefSource>
<PMID Version="1">22506916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Klin Padiatr. 2001 Sep-Oct;213(5):285-7</RefSource>
<PMID Version="1">11582527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>ACS Chem Biol. 2016 Jul 15;11(7):2011-20</RefSource>
<PMID Version="1">27198630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Respiration. 2005 Jul-Aug;72(4):335-44</RefSource>
<PMID Version="1">16088272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Jul 29;280(30):27839-49</RefSource>
<PMID Version="1">15923179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(4):e35457</RefSource>
<PMID Version="1">22536387</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Chem. 2014 Feb 13;57(3):817-27</RefSource>
<PMID Version="1">24428728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Inf Model. 2009 Dec;49(12):2749-60</RefSource>
<PMID Version="1">19994843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Infect Dis. 2003 Mar;14(2):123-5</RefSource>
<PMID Version="1">18159435</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Feb 3;287(6):4335-47</RefSource>
<PMID Version="1">22170069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Immunol. 2002 Mar;55(3):242-55</RefSource>
<PMID Version="1">11940231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Microbiol. 2015 Apr 14;6:305</RefSource>
<PMID Version="1">25926825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Aided Mol Des. 2013 Mar;27(3):221-34</RefSource>
<PMID Version="1">23579614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lett Appl Microbiol. 2016 Mar;62(3):221-9</RefSource>
<PMID Version="1">26671758</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2010 Jun 10;115(23):4635-43</RefSource>
<PMID Version="1">20308598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbes Infect. 2004 Feb;6(2):221-8</RefSource>
<PMID Version="1">15049333</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Pulm Med. 2013 May;19(3):251-8</RefSource>
<PMID Version="1">23449384</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Drug Discov. 2009 Aug;8(8):661-77</RefSource>
<PMID Version="1">19629075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Immunol. 2009 Dec;47(2-3):233-46</RefSource>
<PMID Version="1">19828202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Immunol. 2011 Jun 28;2:23</RefSource>
<PMID Version="1">22566813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2009 May;77(5):2065-75</RefSource>
<PMID Version="1">19237519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2007 Mar;51(3):1085-8</RefSource>
<PMID Version="1">17158942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2005 Dec;26(16):1701-18</RefSource>
<PMID Version="1">16211538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Microbiol Rev. 2002 Apr;15(2):194-222</RefSource>
<PMID Version="1">11932230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2011 Sep;7(9):e1002238</RefSource>
<PMID Version="1">21909279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pediatr Pulmonol. 2015 Oct;50 Suppl 40:S31-8</RefSource>
<PMID Version="1">26335953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2009 May 30;373(9678):1891-904</RefSource>
<PMID Version="1">19403164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Immunol. 2015 Oct;67(2 Pt A):75-88</RefSource>
<PMID Version="1">25757815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Chem. 2005 Dec;26(16):1752-80</RefSource>
<PMID Version="1">16211539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Syst Evol Microbiol. 2015 Jul;65(7):2265-71</RefSource>
<PMID Version="1">25872960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Theory Comput. 2008 Jan;4(1):116-22</RefSource>
<PMID Version="1">26619985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Struct Biol. 2008 Oct;18(5):567-76</RefSource>
<PMID Version="1">18809496</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 Dec 10;8(12):e83077</RefSource>
<PMID Version="1">24340081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycoconj J. 1995 Jun;12(3):331-49</RefSource>
<PMID Version="1">7496148</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Syst Evol Microbiol. 2001 Jul;51(Pt 4):1481-90</RefSource>
<PMID Version="1">11491349</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Glycobiology. 2015 Jan;25(1):88-100</RefSource>
<PMID Version="1">25190359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2008 Jan;4(1):e2</RefSource>
<PMID Version="1">18179282</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2010 Jan 13;18(1):59-72</RefSource>
<PMID Version="1">20152153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Jul 18;278(29):27059-67</RefSource>
<PMID Version="1">12732625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Protein Eng. 1995 Feb;8(2):127-34</RefSource>
<PMID Version="1">7630882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014 Feb 12;9(2):e88094</RefSource>
<PMID Version="1">24533068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Inf Model. 2011 Oct 24;51(10):2778-86</RefSource>
<PMID Version="1">21919503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Chem Theory Comput. 2008 Mar;4(3):435-47</RefSource>
<PMID Version="1">26620784</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Burkholderia ambifaria</Keyword>
<Keyword MajorTopicYN="N">blood group determinants</Keyword>
<Keyword MajorTopicYN="N">docking</Keyword>
<Keyword MajorTopicYN="N">fucose</Keyword>
<Keyword MajorTopicYN="N">molecular dynamics</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>03</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>06</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28680402</ArticleId>
<ArticleId IdType="doi">10.3389/fphar.2017.00393</ArticleId>
<ArticleId IdType="pmc">PMC5478714</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Dingjan, Tamir" sort="Dingjan, Tamir" uniqKey="Dingjan T" first="Tamir" last="Dingjan">Tamir Dingjan</name>
</noRegion>
<name sortKey="Ramsland, Paul A" sort="Ramsland, Paul A" uniqKey="Ramsland P" first="Paul A" last="Ramsland">Paul A. Ramsland</name>
<name sortKey="Yuriev, Elizabeth" sort="Yuriev, Elizabeth" uniqKey="Yuriev E" first="Elizabeth" last="Yuriev">Elizabeth Yuriev</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Imberty, Anne" sort="Imberty, Anne" uniqKey="Imberty A" first="Anne" last="Imberty">Anne Imberty</name>
</noRegion>
<name sortKey="Perez, Serge" sort="Perez, Serge" uniqKey="Perez S" first="Serge" last="Pérez">Serge Pérez</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000785 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000785 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:28680402
   |texte=   Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:28680402" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024